DDX19A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.270400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.397980E-01
Normal-vs-Stage2
5.816400E-01
Normal-vs-Stage3
1.605990E-01
Normal-vs-Stage4
2.401600E-01
Stage1-vs-Stage2
4.765200E-01
Stage1-vs-Stage3
3.878400E-01
Stage1-vs-Stage4
9.623300E-03
Stage2-vs-Stage3
1.579410E-01
Stage2-vs-Stage4
7.111600E-02
Stage3-vs-Stage4
2.947800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.384000E-01
Normal-vs-AfricanAmerican
9.713200E-01
Normal-vs-Asian
1.723790E-01
Caucasian-vs-AfricanAmerican
4.176800E-01
Caucasian-vs-Asian
1.495240E-01
AfricanAmerican-vs-Asian
1.038650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.331800E-01
Normal-vs-Female
5.352000E-01
Male-vs-Female
6.796400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.350600E-01
Normal-vs-Age(41-60Yrs)
8.142000E-01
Normal-vs-Age(61-80Yrs)
4.015600E-01
Normal-vs-Age(81-100Yrs)
7.683800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.920200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.189800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.105800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.218200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.505800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.162800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.088800E-01
Normal-vs-Daily Drinker
2.825200E-01
Normal-vs-Weekly Drinker
5.921400E-01
Normal-vs-Occasional Drinker
6.720600E-01
Normal-vs-Social Drinker
8.176800E-01
Non Drinker-vs-Daily Drinker
9.117000E-01
Non Drinker-vs-Weekly Drinker
3.801600E-01
Non Drinker-vs-Occasional Drinker
7.395900E-02
Non Drinker-vs-Social Drinker
4.248400E-02
Daily Drinker-vs-Weekly Drinker
4.858600E-01
Daily Drinker-vs-Occasional Drinker
1.352170E-01
Daily Drinker-vs-Social Drinker
8.573700E-02
Weekly Drinker-vs-Occasional Drinker
6.060200E-01
Weekly Drinker-vs-Social Drinker
4.546600E-01
Occasional Drinker-vs-Social Drinker
7.265600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.984000E-01
Normal-vs-Grade 2
8.782000E-01
Normal-vs-Grade 3
8.105800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.088240E-02
Grade 1-vs-Grade 3
1.863380E-03
Grade 1-vs-Grade 4
9.984000E-01
Grade 2-vs-Grade 3
7.251700E-02
Grade 2-vs-Grade 4
8.782000E-01
Grade 3-vs-Grade 4
8.105800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.243200E-01
Normal-vs-NonDiabetic
4.198800E-01
Diabetic-vs-NonDiabetic
4.513400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.864400E-01
Normal-vs-NoPancreatitis
4.102600E-01
Pancreatitis-vs-NoPancreatitis
6.362800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.426200E-01
Normal-vs-N1
6.289400E-01
N0-vs-N1
2.841200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.564000E-01
Normal-vs-TP53-NonMutant
4.561600E-01
TP53-Mutant-vs-TP53-NonMutant
6.322500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
